Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2017-03-27
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To assess protocol feasibility in terms of acceptability to parents and infants.
To inform the design of a future larger study where reference limits will be fully defined across a wider gestational age group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Oxygenation of Newborn Infants in Targeted Oxygen Ranges
NCT03360292
Neonatal Pulse Oximetry Sensor Study
NCT05250102
Trends In Oxygen Saturation In Healthy Term Infants In The First Few Days Of Life: The "TOST" Study
NCT02095041
Initial Oxygen Concentration at Birth in Late-Preterm Infants
NCT07315594
Co2 Monitoring at Preterm Delivery-Observational Study
NCT04699708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Current practice is to maintain premature infants' oxygen saturations between 88 and 93%. After 36 weeks' postmenstrual age, the risk of ROP is greatly reduced and these target oxygen saturations are typically increased to greater than 93%. Lower saturations beyond this time are associated with poor weight gain and are considered to carry a risk of developing pulmonary hypertension (Poets 1998). Many of the smallest and most premature infants will continue to require supplemental inspired oxygen after 36 weeks' postmenstrual age in order to maintain saturations greater than 93%, so called "chronic lung disease of prematurity". Some of these infants will require to be discharged home on supplemental oxygen. The need for home oxygen is determined by measurement of pulse oximetry prior to discharge.
A recently developed device, the Masimo Radical 7, is now in widespread use in preterm infants nearing discharge from the neonatal unit. This device is more accurate (Bohnhorst 2002), derives extra physiological measures from the oxygen saturation data (heart rate and perfusion index) and offers longer-term data storage than other models currently in clinical use. In addition, the Masimo Radical 7 with its analysis software is capable of counting and measuring shorter-term dips in oxygen saturation (Sedowofia 2008). An oxygen saturation study can be measured in terms of the overall oxygen saturation, and/or the number, duration and severity of these dips. Increasing use of the Masimo Radical 7 to record oxygen saturation studies in preterm infants nearing discharge from the neonatal unit has, for a significant number of infants, revealed more than previously suspected episodes of reduced oxygen saturation which are frequently not clinically apparent. Because of a dearth of data recorded from healthy term babies in the immediate newborn period, the "normal" Masimo Radical 7 trace is not well defined and the significance of these short dips in oxygen saturation is not clear. Defining acceptable saturation limits depends on a complete understanding of what is normal: in other words, deriving adequate reference limits from hundreds of healthy neonates (CLSI 2008; Pan 1990).
Multiple studies of oxygen saturation levels in neonates have been conducted, but disparate devices and protocols, and heterogeneity in age, gestation and morbidity of subjects preclude any universal clinical decision limit for normal oxygen saturation profile in prematurely-born neonates. Furthermore, as noted above, most currently-used oxygen saturation monitors do not capture very short-term changes in oxygen saturation.
This study will define preliminary reference limits for pulse oximetry in newly born healthy term babies, in order better to be able to interpret oxygen saturation recordings made in preterm babies nearing term corrected age and hospital discharge. The investigators will assess feasibility of data collection, and use the data to inform a subsequent larger study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed parental consent.
* Delivery by elective caesarean section.
Exclusion Criteria
* Any respiratory or cardiac concerns.
* Treatment for suspected sepsis.
1 Hour
1 Month
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Greater Glasgow and Clyde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Princess Royal maternity
Glasgow, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Helen Mactier, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GN16RM676P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.